These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18953717)

  • 1. Lipopolysaccharide: a tool and target in enterobacterial vaccine development.
    Nagy G; Pál T
    Biol Chem; 2008 May; 389(5):513-20. PubMed ID: 18953717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetically engineered lipopolysaccharide as vaccine adjuvant.
    Zariri A; van der Ley P
    Expert Rev Vaccines; 2015 Jun; 14(6):861-76. PubMed ID: 25797360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an anti-endotoxin vaccine for sepsis.
    Cross AS
    Subcell Biochem; 2010; 53():285-302. PubMed ID: 20593272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine development targeting lipopolysaccharide structure modification.
    Zhao Y; Arce-Gorvel V; Conde-Álvarez R; Moriyon I; Gorvel JP
    Microbes Infect; 2018; 20(9-10):455-460. PubMed ID: 29233768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress toward a vaccine for extraintestinal pathogenic
    Xing Y; Clark JR; Chang JD; Zulk JJ; Chirman DM; Piedra F-A; Vaughan EE; Hernandez Santos HJ; Patras KA; Maresso AW
    Infect Immun; 2024 May; 92(5):e0044023. PubMed ID: 38591882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leucine rich alpha-2-glycoprotein 1 (Lrg1) silencing protects against sepsis-mediated brain injury by inhibiting transforming growth factor beta1 (TGFβ1)/SMAD signaling pathway.
    Miao Y; Wang M; Cai X; Zhu Q; Mao L
    Bioengineered; 2022 Mar; 13(3):7316-7327. PubMed ID: 35264055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Anti-Bacterial Immunity against Systemic Infection by
    Fiorino F; Pettini E; Koeberling O; Ciabattini A; Pozzi G; Martin LB; Medaglini D
    Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34065899
    [No Abstract]   [Full Text] [Related]  

  • 8. Engineering a Novel Bivalent Oral Vaccine against Enteric Fever.
    Soulier A; Prevosto C; Chol M; Deban L; Cranenburgh RM
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33807097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of deletion of gene cluster involved in synthesis of Enterobacterial common antigen on virulence and immunogenicity of live attenuated Salmonella vaccine when delivering heterologous Streptococcus pneumoniae antigen PspA.
    Liu Q; Shen X; Bian X; Kong Q
    BMC Microbiol; 2020 Jun; 20(1):150. PubMed ID: 32513100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A facile approach for development of a vaccine made of bacterial double-layered membrane vesicles (DMVs).
    Wang S; Gao J; Li M; Wang L; Wang Z
    Biomaterials; 2018 Dec; 187():28-38. PubMed ID: 30292939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal
    Schager AE; Dominguez-Medina CC; Necchi F; Micoli F; Goh YS; Goodall M; Flores-Langarica A; Bobat S; Cook CNL; Arcuri M; Marini A; King LDW; Morris FC; Anderson G; Toellner KM; Henderson IR; López-Macías C; MacLennan CA; Cunningham AF
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against
    Fiorino F; Rondini S; Micoli F; Lanzilao L; Alfini R; Mancini F; MacLennan CA; Medaglini D
    Front Immunol; 2017; 8():168. PubMed ID: 28289411
    [No Abstract]   [Full Text] [Related]  

  • 13. Salmonella enterica Serovar Typhi Lipopolysaccharide O-Antigen Modification Impact on Serum Resistance and Antibody Recognition.
    Kintz E; Heiss C; Black I; Donohue N; Brown N; Davies MR; Azadi P; Baker S; Kaye PM; van der Woude M
    Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28167670
    [No Abstract]   [Full Text] [Related]  

  • 14. Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease.
    Lanzilao L; Stefanetti G; Saul A; MacLennan CA; Micoli F; Rondini S
    PLoS One; 2015; 10(10):e0139847. PubMed ID: 26445460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sugar-Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines.
    Stefanetti G; Hu QY; Usera A; Robinson Z; Allan M; Singh A; Imase H; Cobb J; Zhai H; Quinn D; Lei M; Saul A; Adamo R; MacLennan CA; Micoli F
    Angew Chem Int Ed Engl; 2015 Nov; 54(45):13198-203. PubMed ID: 26350581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.
    Szijártó V; Guachalla LM; Visram ZC; Hartl K; Varga C; Mirkina I; Zmajkovic J; Badarau A; Zauner G; Pleban C; Magyarics Z; Nagy E; Nagy G
    Antimicrob Agents Chemother; 2015; 59(6):3109-16. PubMed ID: 25779571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of glycoconjugate vaccines against invasive African Salmonella enterica serovar Typhimurium.
    Rondini S; Micoli F; Lanzilao L; Gavini M; Alfini R; Brandt C; Clare S; Mastroeni P; Saul A; MacLennan CA
    Infect Immun; 2015 Mar; 83(3):996-1007. PubMed ID: 25547792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection from hemolytic uremic syndrome by eyedrop vaccination with modified enterohemorrhagic E. coli outer membrane vesicles.
    Choi KS; Kim SH; Kim ED; Lee SH; Han SJ; Yoon S; Chang KT; Seo KY
    PLoS One; 2014; 9(7):e100229. PubMed ID: 25032703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains.
    Santos MF; New RR; Andrade GR; Ozaki CY; Sant'Anna OA; Mendonça-Previato L; Trabulsi LR; Domingos MO
    Clin Vaccine Immunol; 2010 Nov; 17(11):1772-80. PubMed ID: 20861324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated delayed expression of rfc enhances the immunogenicity and protective efficacy of a heterologous antigen delivered by live attenuated Salmonella enterica vaccines.
    Kong Q; Liu Q; Jansen AM; Curtiss R
    Vaccine; 2010 Aug; 28(37):6094-103. PubMed ID: 20599580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.